Human pharmaceuticals for the treatment of cardiovascular diseases, [ pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, ] diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness [ , infectious diseases ]

[ Technical consulting and ] research in the field of cellular assay screening and pharmaceutical discovery and development; [ consultation, ] collaboration, and research services relating to drug discovery and development [ ; information services relating to drug discovery and development ]

Human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, or skeletal muscle weakness

Technical consulting and research in the field of cellular assay screening, pharmaceutical discovery and development [ and patient diagnosis ]

Oncologic, cardiovascular, infectious disease, neurologic, anti-inflammatory, and ophthalmological pharmaceuticals

automated imaging instruments; software and data analyzers relating to the same; automated sample handling instruments; and software and data analyzers relating to the same

reagents for scientific or medical research use

[ oncologic, cardiovascular, infectious disease, ] neurologic [, anti-inflammatory, and ophthalmological ] pharmaceuticals

consultation and research services relating to drug discovery and development and patient diagnosis